These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

671 related articles for article (PubMed ID: 18355314)

  • 1. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
    Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
    J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.
    Torrent J; Alvarez-Martinez MT; Harricane MC; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2004 Jun; 43(22):7162-70. PubMed ID: 15170353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibril conformation as the basis of species- and strain-dependent seeding specificity of mammalian prion amyloids.
    Jones EM; Surewicz WK
    Cell; 2005 Apr; 121(1):63-72. PubMed ID: 15820679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid fibrils formation and amorphous aggregation in concanavalin A.
    Vetri V; Canale C; Relini A; Librizzi F; Militello V; Gliozzi A; Leone M
    Biophys Chem; 2007 Jan; 125(1):184-90. PubMed ID: 16934387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic acid and prion protein interaction produces spherical amyloids which can function in vivo as coats of spongiform encephalopathy agent.
    Nandi PK; Nicole JC
    J Mol Biol; 2004 Nov; 344(3):827-37. PubMed ID: 15533448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble beta-sheet models which self-assemble into fibrillar structures.
    Janek K; Behlke J; Zipper J; Fabian H; Georgalis Y; Beyermann M; Bienert M; Krause E
    Biochemistry; 1999 Jun; 38(26):8246-52. PubMed ID: 10387070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
    Natalello A; Prokorov VV; Tagliavini F; Morbin M; Forloni G; Beeg M; Manzoni C; Colombo L; Gobbi M; Salmona M; Doglia SM
    J Mol Biol; 2008 Sep; 381(5):1349-61. PubMed ID: 18619462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual soluble beta-turn-rich conformation of prion is involved in fibril formation and toxic to neuronal cells.
    Kazlauskaite J; Young A; Gardner CE; Macpherson JV; Vénien-Bryan C; Pinheiro TJ
    Biochem Biophys Res Commun; 2005 Mar; 328(1):292-305. PubMed ID: 15670783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
    Ollesch J; Künnemann E; Glockshuber R; Gerwert K
    Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils.
    Bocharova OV; Breydo L; Salnikov VV; Baskakov IV
    Biochemistry; 2005 May; 44(18):6776-87. PubMed ID: 15865423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
    Apetri AC; Vanik DL; Surewicz WK
    Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative prion structural changes revealed by high pressure.
    Torrent J; Alvarez-Martinez MT; Heitz F; Liautard JP; Balny C; Lange R
    Biochemistry; 2003 Feb; 42(5):1318-25. PubMed ID: 12564935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen/deuterium exchange mass spectrometry identifies two highly protected regions in recombinant full-length prion protein amyloid fibrils.
    Nazabal A; Hornemann S; Aguzzi A; Zenobi R
    J Mass Spectrom; 2009 Jun; 44(6):965-77. PubMed ID: 19283723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillar beta-lactoglobulin gels: Part 1. Fibril formation and structure.
    Gosal WS; Clark AH; Ross-Murphy SB
    Biomacromolecules; 2004; 5(6):2408-19. PubMed ID: 15530058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.